Intratympanic gentamicin in Ménière's disease: Our experience

Journal of Laryngology and Otology

Volumn 125, Issue 4, 2011, Pages 363-369

  Delgado, L Pérez ^a   Rodrigo, J Fraile ^a   Peña, P Astier ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Ear, Middle; Gentamicin; Therapeutics; Vertigo

Indexed keywords

GENTAMICIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DRUG EFFICACY; FEMALE; HEARING LOSS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; VERTIGO; CLINICAL TRIAL; DRUG ADMINISTRATION; EARDRUM; EPIDEMIOLOGY; MIDDLE AGED; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; EPIDEMIOLOGIC METHODS; FEMALE; GENTAMICINS; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 79958762057     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215111000053     Document Type: Article

References (27)

1. Fowler E. Toxicity of streptomycin for the auditory and vestib-ular mechanisms. Trans Am Acad Ophthalmol Otolaryngol 1948;52:293-301
2. Schuknecht HF. Ablation therapy in the management of Menière's disease. Acta Otolaryngol Suppl 1957;132:1-42
3. Beck C, Schmidt CL. 10 years of experience with intratympanally applied streptomycin (gentamicin) in the therapy of Morbus Menière. Arch Otorhinolaryngol 1978;221: 149-52 (Pubitemid 9027145)
4. The Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:186-7
5. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gen-tamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 2004;25:544-52 (Pubitemid 39079778)
6. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19 (Pubitemid 29476649)
7. Hirsch BE, Kamerer DB. Intratympanic gentamicin therapy for Ménière's disease. Am J Otol 1997;18:44-51 (Pubitemid 27057792)
8. Perez N, Martín E, García-Tapia R. Intratympanic gentamicin for intractable Meniere's disease. Laryngoscope 2003;113: 456-64 (Pubitemid 36292870)
9. Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H et al. Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007;117: 415-20 (Pubitemid 46407747)
10. Abou-Halawa AS, Poe DS. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease. Otol Neurotol 2002;23:494-502, 502-3
11. Kaasinen S, Pyykkö I, Ishizaki H, Aalto H. Intratympanic gen-tamicin in Ménière's disease. Acta Otolaryngol 1998;118: 294-8
12. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Ménière's disease: a preliminary report. Laryngoscope 1997;107:49-55 (Pubitemid 27045194)
13. Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentami-cin. Laryngoscope 2007;117:1474-81 (Pubitemid 47356857)
14. Stahle J, Bergman B. The caloric reaction in Ménière's disease. Laryngoscope 1967;77:1629-43
15. Dobie RA, Snyder JM, Donaldson JA. ENG and audiologic findings in patients with Ménière's disease. Acta Otolaryngol 1982;94:19-27 (Pubitemid 12085954)
16. Hulshof JH, Baarsma EA. Follow-up vestibular examination in Menière's disease. Acta Otolaryngol 1981;92:397-401 (Pubitemid 12228680)
17. Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease. Laryngoscope 2004;114:102-5 (Pubitemid 38141075)
18. Bertino G, Durso D, Manfrin M, Casati L, Mira E. Intratympanic gentamicin in monolateral Meniere's disease: our experience. Eur Arch Otorhinolaryngol 2006;263:271-5
19. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope 2004;114:2085-91 (Pubitemid 39602470)
20. Carey J. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo. Otolaryngol Clin North Am 2004;37:1075-90 (Pubitemid 39335774)
21. Harner SG, Driscoll CL, Facer GW, Beatty CW, McDonald TJ. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome. Otol Neurotol 2001;22:210-14 (Pubitemid 32233476)
22. Flanagan S, Mukherjee P, Tonkin J. Outcomes in the use of intra-tympanic gentamicin in the treatment of Ménière's disease. J Laryngol Otol 2006;120:98-102 (Pubitemid 46825656)
23. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-20 (Pubitemid 36539153)
24. Peterson WM, Isaacson JE. Current management of Ménière's disease in an only hearing ear. Otol Neurotol 2007; 28:696-9 (Pubitemid 47229718)
25. Blakley BW. Update on intratympanic gentamicin for Méniè re's disease. Laryngoscope 2000;110:236-40 (Pubitemid 30090854)
26. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of monolateral Ménière's disease. Laryngoscope 2000;110:1298-305 (Pubitemid 30626096)
27. Assimakopoulos D, Patrikakos G. Treatment of Ménière's disease by intratympanic gentamicin application. J Laryngol Otol 2003;117:10-16 (Pubitemid 36084234)